>> 全站文章索引 >> 第23页: Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial - [Pinhas N. Dannon, Yehuda Sasson, Shmuel Hirschmann, Iulian Iancu, Leon J. Grunhaus and Joseph Zohar] Paroxetine binding to the rat norepinephrine transporter in vivo - [Michael J. Owens, David L. Knight and Charles B. Nemeroff] The serotonin transporter in the midbrain of suicide victims with major depression - [William Bligh-Glover, Tamara N. Kolli, Laura Shapiro-Kulnane, Ginny E. Dilley, Lee Friedman, Elizabeth Balraj, Grazyna Rajkowska and Craig A. Stockmeier] Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography - [E. Lacassie, J. -M. Gaulier, P. Marquet, J. -F. Rabatel and G. Lachatre] Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain - [Frank I. Tarazi, Kehong Zhang and Ross J. Baldessarini] Serotonin Reuptake Is Less Efficient in Taste Aversion Resistant Than in Taste Aversion-Prone Rats - [R. L. Elkins, T. E. Orr, J. Q. Li, P. A. Walters, J. L. Whitford, G. F. Carl and J. L. Rausch] Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study - [Murray B. Stein, G. Ron Norton, John R. Walker, Mariette J. Chartier and Roger Graham] The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared - [R. A. Lawrenson, F. Tyrer, R. B. Newson and R. D. T. Farmer] Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression - [Maurizio Fava, Jerrold F. Rosenbaum, Sharon L. Hoog, Rosalinda G. Tepner, Joan B. Kopp and Mary E. Nilsson] Open-label trial of paroxetine in children with obsessive-compulsive disorder - [Rasim Somer Diler and Ayse Avci] The question of feedback at the somadendritic region and antidepressant drug action - [Stanley Kalsner] Thalamic volume in pediatric obsessive–compulsive disorder patients before and after cognitive behavioral therapy - [David R. Rosenberg, Nili R. Benazon, Andrew Gilbert, April Sullivan and Gregory J. Moore] 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation - [Yukihiko Shirayama, Kenji Hashimoto, Masaomi Iyo, Kei-ichiro Watanabe, Teruhiko Higuchi and Yoshio Minabe] The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test - [Martine Hasco?t, Michel Bourin and Brid A. Nic Dhonnchadha] Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring - [H. Dix Christensen, William F. Rayburn and Christina L. Gonzalez] Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat - [Jean-Claude Bé?que, Claude de Montigny, Pierre Blier and Guy Debonnel] Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults - [M. Philipp, J. W. G. Tiller, D. Baier and R. Kohnen] Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity - [Ulrich W. Preuss, Michael Soyka, Miriam Bahlmann, Karin Wenzel, Stefanie Behrens, Sylvia de Jonge, Marc Krüger and Brigitta Bondy] Antidepressants: past, present and future - [Jerzy Vetulani and Irena Nalepa] Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine - [S. C. Cheetham, J. A. Viggers, N. A. Slater and D. J. Heal] Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil - [L. Ferraro, K. Fuxe, S. Tanganelli, M. Fernandez, F. A. Rambert and T. Antonelli] Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment - [N. Brunello, J. A. den Boer, L. L. Judd, S. Kasper, J. E. Kelsey, M. Lader, Y. Lecrubier, J. P. Lepine, R. B. Lydiard, J. Mendlewicz, et al.] P01.15 Neurocognitive changes in adjustment disorder with depressed mood: Use of paroxetine - [.] Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions - [T. A. Slotkin, F. J. Seidler and S. F. Ali] Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine - [éva Hajós-Korcsok, Sarah F. B. McTavish and Trevor Sharp] LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone - [Ian A. Pullar, Stephen L. Carney, Ellen M. Colvin, Virginia L. Lucaites, David L. Nelson and Susan Wedley] Do antidepressants affect motivation in conditioned place preference? - [Fazal Subhan, Paul N. Deslandes, David M. Pache and Robert D. E. Sewell] Treatment of depression and concomitant anxiety - [David Nutt] The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome - [Cameron R. Hernandez, Gwenn S. Smith, Patricia R. Houck, Bruce G. Pollock, Benoit Mulsant, Mary Amanda Dew and Charles F. Reynolds III] Serotonergic markers and lowered plasma branched-chain-amino acid concentrations in fibromyalgia - [Michael Maes, Robert Verkerk, Laure Delmeire, Ann Van Gastel, Fran van Hunsel and Simon Scharpé] Serotonin transporter inhibitors: synthesis and binding potency of 2′-methyl- and 3′-methyl-6-nitroquipazine - [John M. Gerdes, Steven C. DeFina, Paul A. Wilson and Scott E. Taylor] Salmon calcitonin potentiates the analgesia induced by antidepressants - [María Jesús Ormazábal, Carlos Goicoechea, Eva Sánchez and María Isabel Martín] Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain - [Katsumasa Muneoka, Tetsuo Ogawa, Kenji Kamei, Yuichi Mimura, Hitomi Kato and Morikuni Takigawa] Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures - [Carolyn S. Dewa, Jeffrey S. Hoch and Paula Goering] Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats - [Andrew Harkin, Thomas J. Connor, Jane Mulrooney, John P. Kelly and Brian E. Leonard] Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder - [Mats Humble, Susanne Bejerot, Peter B. F. Bergqvist and Finn Bengtsson] Asymmetric syntheses of trans-3,4-disubstituted 2-piperidinones and piperidines - [Lee Tai Liu, Pao-Chiung Hong, Hsiang-Ling Huang, Shyh-Fong Chen, Chia-Lin Jeff Wang and Yuh-Sheng Wen] Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? - [Denis Joseph Paul David, Bríd á. Nic Dhonnchadha, Pascale Jolliet, Martine Hasco?t and Michel Bourin] Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs - [Luca Ferraro, Sergio Tanganelli, Kjell Fuxe, Bertha Wonje Bebe, Maria Cristina Tomasini, Francis A. Rambert and Tiziana Antonelli] Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the wistar rat - [Eamond D. O] Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder - [Lorrin M. Koran, Stefano Pallanti and Leonardo Quercioli] Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice - [Florence Clenet, Anouk De Vos and Michel Bourin] Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors - [M. H. Nelson, A. K. Birnbaum and R. P. Remmel] Methylenedioxymethamphetamine-induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin - [Thomas J. Connor, Michael C. Dennedy, Andrew Harkin and John P. Kelly] Récepteurs 5-HT1B de la sérotonine et effets antidépresseurs des inhibiteurs de recapture sélectifs de la sérotonine5-HT1B receptors mediate the antidepressant effects of selective serotonin reuptake inhibitors. - [Alain M. Gardier, Anne-Cécile Trillat, Isabelle Malagié, Denis David, Martine Hasco?t, Marie-Claude Colombel, Pascale Jolliet, Christian Jacquot, René Hen and Michel Bourin] Retinopathy associated with high-dose interferon alfa-2b therapy - [Charles Hejny, Paul Sternberg, David H. Lawson, Kristen Greiner and Thomas M. Aaberg] An open study of paroxetine in hypochondriasis - [Desiree B. Oosterbaan, Anton J. L. M. Van Balkom, Christine A. Van Boeijen, Tim GJ De Meij and Richard van Dyck] Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? - [Thomas I. F. H. Cremers, Loes J. Wiersma, Fokko J. Bosker, Johan A. den Boer, Ben H. C. Westerink and H?kan V. Wikstr?m] Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment - [M. Bixo, P. Allard, T. B?ckstr?m, T. Mj?rndal, S. Nyberg, O. Spigset and I. Sundstr?m-Poromaa] Brain metabolic changes associated with symptom factor improvement in major depressive disorder - [Arthur L. Brody, Sanjaya Saxena, Mark A. Mandelkern, Lynn A. Fairbanks, Matthew L. Ho and Lewis R. Baxter] Ring expansion: formal total synthesis of (?)-paroxetine - [Janine Cossy, Olivier Mirguet, Domingo Gomez Pardo and Jean-Roger Desmurs] Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine - [Michael J. Owens, David L. Knight and Charles B. Nemeroff] Decreased platelet [3H]paroxetine binding sites in suicide attempters - [Antonella Armani, Gino Giannaccini, Elena Di Nasso, Antonio Lucacchini and Giovanni B. Cassano] Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos - [Kimberly W. Raines, Frederic J. Seidler and T. A. Slotkin] High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum - [G. Tournel, N. Houdret, V. Hédouin, M. Deveaux, D. Gosset and M. Lhermitte] Fetal and adolescent nicotine administration: effects on CNS serotonergic systems - [Z. Xu, F. J. Seidler, S. F. Ali, W. Slikker and T. A. Slotkin] Tryptophan hydroxylase gene associated with paroxetine antidepressant activity - [Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Cristina Lorenzi and Enrico Smeraldi] A short formal synthesis of paroxetine. Diastereoselective cuprate addition to a chiral racemic olefinic amido ester - [Janine Cossy, Olivier Mirguet, Domingo Gomez Pardo and Jean-Roger Desmurs] Status of minor depression or dysthymia in primary care following a randomized controlled treatment - [Thomas E. Oxman, James E. Barrett, Anjana Sengupta, Wayne Katon, John W. Williams, Ellen Frank and Mark Hegel] Endogenous concentrations of DHEA and DHEA-S Decrease with remission of depression in older adults - [Tanya J. Fabian, Mary Amanda Dew, Bruce G. Pollock, Charles F. Reynolds, Benoit H. Mulsant, Meryl A. Butters, Michelle D. Zmuda, Ana M. Linares, Mario Trottini and Patricia D. Kroboth] No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors - [Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Roberta Lilli, Cristina Lorenzi, Enrico Lattuada and Enrico Smeraldi] In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties - [Ian A. Pullar, John R. Boot, Stephen L. Carney, Marlene L. Cohen, Ellen M. Colvin, Richard G. Conway, Clare H. L. Hardy, Virginia L. Lucaites, David L. Nelson, Kathryn W. Schenck, et al.] Effects of long-term lithium treatment on monoaminergic functions in major depression - [Aram El Khoury, Lars Johnson, Anna ?berg-Wistedt and Rigmor Stain-Malmgren] A survey of prescribing practices in the treatment of depression - [Timothy Petersen, Christina Dording, Nicole B. Neault, Rebecca Kornbluh, Jonathan E. Alpert, Andrew A. Nierenberg, Jerrold F. Rosenbaum and Maurizio Fava] Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects - [Isabelle Loubinoux, Jérémie Pariente, Olivier Rascol, Pierre Celsis and Fran?ois Chollet] A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects - [Isabelle Loubinoux, Jérémie Pariente, Kader Boulanouar, Christophe Carel, Claude Manelfe, Olivier Rascol, Pierre Celsis and Fran?ois Chollet] The effect of changes in depression on health related quality of life (HRQoL) in HIV infection - [Andrew J. Elliott, Joan Russo and Peter P. Roy-Byrne] Predictors of nonresponse to treatment in primary care patients with dysthymia - [Wayne Katon, Joan Russo, Ellen Frank, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell] Correlates of remission in primary care patients treated for minor depression - [Ellen Frank, Paola Rucci, Wayne Katon, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell] Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes - [P. Molander, A. Thomassen, L. Kristoffersen, T. Greibrokk and E. Lundanes] The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain - [Tatsuji Tamura, Shigeru Morinobu, Yasumasa Okamoto, Ariyuki Kagaya and Shigeto Yamawaki] Selective serotonin reuptake inhibitor discontinuation syndrome in children: Six case reports - [Rasim Somer Diler and Ayse Avci] Impaired release of β-endorphin in response to serotonin in a rat model of depression - [A. Zangen, R. Nakash, I. Roth-Deri, D. H. Overstreet and G. Yadid] The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT1B receptor knockout mice - [Lotte De Groote, Berend Olivier and Herman G. M. Westenberg] Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: A pharmacological characterization of diverse classes of antidepressant agents - [Mauricette Brocco, Anne Dekeyne, Sylvie Veiga, Sylvie Girardon and Mark J. Millan] Paroxetine alters KCl- or ATP-induced contractile responses of isolated vas deferens in rats chronically treated with ethanol - [Murat Kesim, Mine Kadioglu, Ersin Yaris, Nuri Ihsan Kalyoncu, Rasin Ozyavuz and Cunay Ulku] Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos - [Kimberly W. Raines, Frederic J. Seidler and T. A. Slotkin] Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment - [M. Bixo, P. Allard, T. B?ckstr?m, T. Mj?rndal, S. Nyberg, O. Spigset and I. Sundstr?m-Poromaa] Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression - [Department of Psychiatry, University of Washington, Seattle 98195, USA.] Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial - [Michael J. Detke, Curtis G. Wiltse, Craig H. Mallinckrodt, Robert K. McNamara, Mark A. Demitrack and Istvan Bitter] Quality of life after treatment for incidental, unruptured intracranial aneurysms - [Solheim O, Eloqayli H, Muller TB, Unsgaard G.] Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial - [Dr. W. Katon, Department of Psychiatry, Univ. of Washington School of Med., Box 35-6560, Seattle, WA 98195; United States. E-Mail: wkaton@u.washington.edu.] Auditory Evoked Potentials Reflect Serotonergic Neuronal Activity?A Study in Behaving Cats Administered Drugs Acting on 5-HT1A Autoreceptors in the Dorsal Raphe Nucleus - [Georg Juckel1 MD, Ulrich Hegerl1 MD, Ph.D, Márk Molnár2 MD, Ph.D, Valéria Csépe2 Ph.D and George Karmos2 MD, Ph.D] How psychotherapy changes the brain – the contribution of functional neuroimaging - [D E J Linden1,2] Does blinding of readers affect the results of meta-analyses? - [Jesse A Berlin] Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression - [Zanardi, Raffaella, Franchini, Linda, Gasperini, Mariangela, Perez, Jorge, Smeraldi, Enrico] Drug Metabolism Reviews 301-400 - [.] Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period - [Brian J. Piper and Jerrold S. Meyer] Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo - [Inger Lise Bogen, Kristin Huse Haug, Oddvar Myhre and Frode Fonnum] Characterization of the Translocation of Protein Kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy) in Synaptosomes: Evidence for a Presynaptic Localization Involving the Serotonin Transporter (SERT) - [H Kenneth Kramer1 MD, Ph.D, Jose C Poblete2 Ph.D and Efrain C Azmitia2 Ph.D] Effect of Subchronic Antidepressant Treatments on Behavioral, Neurochemical, and Endocrine Changes in the Forced-Swim Test - [Thomas J. Connor, Padraig Kelliher, Yan Shen, Andrew Harkin, John P. Kelly and Brian E. Leonard] 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand - [Shunichi Oya, Seok-Rye Choi, Catherine Hou, Mu Mu, Mei-Ping Kung, Paul D. Acton, Michael Siciliano and Hank F. Kung] Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia - [.] Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors - [J. L. Munoz-Bellido, S. Munoz-Criado and J. A. Garcìa-Rodrìguez] Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis - [Isabelle Malagié, Antoine Deslandes and Alain M. Gardier] Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake - [Elena Consogno, Cinzia Dorigo, Giorgio Racagni and Maurizio Popoli] Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? - [Linda Franchini, David Rossini, Fanny Bongiorno, Chiara Spagnolo, Enrico Smeraldi and Raffaella Zanardi] Ontogeny of drug-metabolizing enzymes and its influence on the pathogenesis of adverse drug reactions in children - [J. Steven Leeder] Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with α-[14C]methyl--tryptophan - [Fumitaka Yamane, Hidehiko Okazawa, Pierre Blier and Mirko Diksic] Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons - [Steven T. Szabo and Pierre Blier] 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 [23] 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50